Concepedia

Author

Hooman Beygi

Teva Pharmaceuticals (United States)

Also Known As

H. Beygi, Hooman Beygi

10

Publications

81

Citations

4

H-Index

16

Concepts

All Affiliations

Teva Pharmaceuticals (United States)
HB

About

Hooman Beygi is an author at Teva Pharmaceuticals (United States) specializing in hematology, medicine, and iga glomerulonephritis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

30

2

Hematology

2

2

30

3

Immunology

1

1

13

4

Nephrology

1

1

17

5

Pathology

1

1

17

Hooman Beygi

×

3

Publications

69

Citations

3

H-Index

YearCitations

Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects

Frank Schneider, Lavi Erisson, Hooman Beygi,

British Journal of Clinical Pharmacology

2018

39

The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis

Beth Nordstrom, Kevin Knopf, Dana Y. Teltsch,

Leukemia & lymphoma/Leukemia and lymphoma

2013

17

Therapeutic Advances in Hematology

Kathryn S. Kolibaba, James A. Sterchele, Avani Joshi,

2013

13

Page 1